Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Katie Tuininga et al.|Cell stem cell|2021Cited by 153
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targetingKristin M. Snyder, Bruce Walcheck, Kate Dixon et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 21
Engineered iPSC-Derived NK Cells Expressing Recombinant CD64 for Enhanced ADCCKate Dixon, Bruce Walcheck, Robert Hullsiek et al.|Blood|2020Cited by 8
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphomaKate Dixon, Bruce Walcheck, Kristin M. Snyder et al.|Frontiers in Immunology|2024Cited by 7
Arming of iPSC-Derived NK Cells Expressing a Novel CD64 Fusion Receptor with Therapeutic Antibodies Represents a Novel Off-the-Shelf, Antigen-Targeting Strategy for CancerKate Dixon, Bruce Walcheck, Kristin M. Snyder et al.|Blood|2021Cited by 0